Bio Rad Laboratories Inc

Common Name

Bio Rad Laboratories

Country

United States

Sector

Healthcare

Industry

Medical Devices

Employees

7,700

Ticker

BIO

Exchange

NEW YORK STOCK EXCHANGE, INC.

Website

www.bio-rad.com

Description

Bio-Rad Laboratories Inc. operates as a leading manufacturer and distributor of life science research products and clinical diagnostics systems. Established in 1952 and headquartered in Hercules, Cali... Show more

Financial Statements of Bio Rad Laboratories

Below are the financial statements of Bio Rad Laboratories, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	488.1^a	403.8^a
Short-term investments	1,176.4^a	1,203.3^a
Restricted investments	0^a	5.6^a
Accounts receivable, less allowance for credit losses	452.5^a	489^a
Inventory	760^a	780.5^a
Prepaid expenses	122.6^a	140^a
Other current assets	30.7^a	26.1^a
Total current assets	3,030.3^a	3,048.3^a
Assets	—	—
Property, plant and equipment, net	528.1^a	529^a
Operating lease right-of-use assets	160.5^a	194.7^a
Goodwill, net	410.5^a	413.6^a
Purchased intangibles, net	293.6^a	320.5^a
Other investments	4,839.2^a	7,698.1^a
Other assets	101.9^a	94.9^a
Total assets	9,364.1^a	12,299.1^a
Current liabilities	—	—
Accounts payable	122.3^a	144.6^a
Accrued payroll and employee benefits	124.2^a	139.9^a
Current maturities of long-term debt and notes payable	1.2^a	0.5^a
Income and other taxes payable	31.2^a	35.8^a
Current operating lease liabilities	41.7^a	40.4^a
Other current liabilities	147.2^a	161.6^a
Total current liabilities	467.8^a	522.8^a
Liabilities and stockholders' equity	—	—
Long-term debt, net of current maturities	1,200.4^a	1,199.1^a
Deferred income taxes	818^a	1,475.5^a
Operating lease liabilities	131.4^a	165.5^a
Other long-term liabilities	177.2^a	195^a
Total liabilities	2,794.8^a	3,557.9^a
Stockholders' equity	—	—
Preferred stock	0^a	0^a
Class A common stock	0^a	0^a
Class B common stock	0^a	0^a
Additional paid-in capital	463.2^a	449.1^a
Class A treasury stock at cost	-772.1^a	-632.5^a
Retained earnings	7,416.4^a	9,260.6^a
Accumulated other comprehensive loss	-538.2^a	-336^a
Total stockholders' equity	6,569.3^a	8,741.2^a
Total liabilities and stockholders' equity	9,364.1^a	12,299.1^a

Verified Sources Behind Bio Rad Laboratories’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bio Rad Laboratories’s data sources below and access millions more through our Disclosure Search.

a. Bio Rad Laboratories's Annual Report 2024

Trace every data point back to Bio Rad Laboratories’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Bio Rad Laboratories Inc

Financial Statements of Bio Rad Laboratories

Verified Sources Behind Bio Rad Laboratories’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Dexcom Inc

Globus Medical Inc

Insulet Corp

Stryker Corp

Procept Biorobotics Corp

Masimo Corp